-
Je něco špatně v tomto záznamu ?
Microbiological diagnostics of bloodstream infections in Europe-an ESGBIES survey
EA. Idelevich, H. Seifert, M. Sundqvist, L. Scudeller, S. Amit, A. Balode, A. Bilozor, P. Drevinek, Z. Kocak Tufan, A. Koraqi, B. Lamy, I. Mareković, J. Miciuleviciene, M. Müller Premru, A. Pascual, S. Pournaras, V. Saegeman, HC. Schønheyder, J....
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
- MeSH
- diagnostické techniky molekulární metody MeSH
- diagnostické testy rutinní metody MeSH
- lidé MeSH
- mikrobiologické techniky metody MeSH
- průřezové studie MeSH
- sepse diagnóza MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Evropa MeSH
OBJECTIVES: High-quality diagnosis of bloodstream infections (BSI) is important for successful patient management. As knowledge on current practices of microbiological BSI diagnostics is limited, this project aimed to assess its current state in European microbiological laboratories. METHODS: We performed an online questionnaire-based cross-sectional survey comprising 34 questions on practices of microbiological BSI diagnostics. The ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES) was the primary platform to engage national coordinators who recruited laboratories within their countries. RESULTS: Responses were received from 209 laboratories in 25 European countries. Although 32.5% (68/209) of laboratories only used the classical processing of positive blood cultures (BC), two-thirds applied rapid technologies. Of laboratories that provided data, 42.2% (78/185) were able to start incubating BC in automated BC incubators around-the-clock, and only 13% (25/192) had established a 24-h service to start immediate processing of positive BC. Only 4.7% (9/190) of laboratories validated and transmitted the results of identification and antimicrobial susceptibility testing (AST) of BC pathogens to clinicians 24 h/day. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry from briefly incubated sub-cultures on solid media was the most commonly used approach to rapid pathogen identification from positive BC, and direct disc diffusion was the most common rapid AST method from positive BC. CONCLUSIONS: Laboratories have started to implement novel technologies for rapid identification and AST for positive BC. However, progress is severely compromised by limited operating hours such that current practice of BC diagnostics in Europe complies only partly with the requirements for optimal BSI management.
Clinical Microbiology Laboratory University Hospital Centre 'Mother Theresa' Tirana Albania
Department of Clinical Microbiology Aalborg University Hospital Aalborg Denmark
Department of Clinical Microbiology and Infectious Diseases Hadassah Medical Centre Jerusalem Israel
Department of Infection Control and Epidemiology University Hospitals Leuven Leuven Belgium
Department of Medical Microbiology Faculty of Medicine Medical University of Sofia Sofia Bulgaria
Department of Microbiology University Hospitals Plymouth NHS Trust Plymouth UK
Division of Epidemiology Tel Aviv Sourasky Medical Centre Tel Aviv Israel
German Centre for Infection Research Partner Site Bonn Cologne Cologne Germany
Institute for Medical Microbiology Immunology and Hygiene University of Cologne Cologne Germany
Institute of Medical Microbiology University Hospital Münster Münster Germany
Microbiology Laboratory Diagnostic Clinic East Tallinn Central Hospital Tallinn Estonia
National Medicines Institute Warsaw Poland
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20006462
- 003
- CZ-PrNML
- 005
- 20200525092233.0
- 007
- ta
- 008
- 200511s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.cmi.2019.03.024 $2 doi
- 035 __
- $a (PubMed)30980927
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Idelevich, E A $u Institute of Medical Microbiology, University Hospital Münster, Münster, Germany.
- 245 10
- $a Microbiological diagnostics of bloodstream infections in Europe-an ESGBIES survey / $c EA. Idelevich, H. Seifert, M. Sundqvist, L. Scudeller, S. Amit, A. Balode, A. Bilozor, P. Drevinek, Z. Kocak Tufan, A. Koraqi, B. Lamy, I. Mareković, J. Miciuleviciene, M. Müller Premru, A. Pascual, S. Pournaras, V. Saegeman, HC. Schønheyder, J. Schrenzel, T. Strateva, R. Tilley, WJ. Wiersinga, D. Zabicka, Y. Carmeli, K. Becker, ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES),
- 520 9_
- $a OBJECTIVES: High-quality diagnosis of bloodstream infections (BSI) is important for successful patient management. As knowledge on current practices of microbiological BSI diagnostics is limited, this project aimed to assess its current state in European microbiological laboratories. METHODS: We performed an online questionnaire-based cross-sectional survey comprising 34 questions on practices of microbiological BSI diagnostics. The ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES) was the primary platform to engage national coordinators who recruited laboratories within their countries. RESULTS: Responses were received from 209 laboratories in 25 European countries. Although 32.5% (68/209) of laboratories only used the classical processing of positive blood cultures (BC), two-thirds applied rapid technologies. Of laboratories that provided data, 42.2% (78/185) were able to start incubating BC in automated BC incubators around-the-clock, and only 13% (25/192) had established a 24-h service to start immediate processing of positive BC. Only 4.7% (9/190) of laboratories validated and transmitted the results of identification and antimicrobial susceptibility testing (AST) of BC pathogens to clinicians 24 h/day. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry from briefly incubated sub-cultures on solid media was the most commonly used approach to rapid pathogen identification from positive BC, and direct disc diffusion was the most common rapid AST method from positive BC. CONCLUSIONS: Laboratories have started to implement novel technologies for rapid identification and AST for positive BC. However, progress is severely compromised by limited operating hours such that current practice of BC diagnostics in Europe complies only partly with the requirements for optimal BSI management.
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a diagnostické testy rutinní $x metody $7 D003955
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mikrobiologické techniky $x metody $7 D008828
- 650 _2
- $a diagnostické techniky molekulární $x metody $7 D025202
- 650 _2
- $a sepse $x diagnóza $7 D018805
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Seifert, H $u Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Cologne, Germany; German Centre for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany.
- 700 1_
- $a Sundqvist, M $u Department of Laboratory Medicine, Clinical Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
- 700 1_
- $a Scudeller, L $u Clinical Epidemiology Unit, Scientific Direction, Fondazione IRCCS, Policlinico San Matteo Pavia Fondazione IRCCS, Pavia, Italy.
- 700 1_
- $a Amit, S $u Department of Clinical Microbiology and Infectious Diseases, Hadassah Medical Centre, Jerusalem, Israel.
- 700 1_
- $a Balode, A $u Pauls Stradins Clinical University Hospital, Riga, Latvia.
- 700 1_
- $a Bilozor, A $u Microbiology Laboratory, Diagnostic Clinic, East-Tallinn Central Hospital, Tallinn, Estonia.
- 700 1_
- $a Drevinek, P $u Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
- 700 1_
- $a Kocak Tufan, Z $u Infectious Diseases and Clinical Microbiology Department, Medical School of Ankara Yildirim Beyazit University, Ankara, Turkey.
- 700 1_
- $a Koraqi, A $u Clinical Microbiology Laboratory, University Hospital Centre 'Mother Theresa', Tirana, Albania.
- 700 1_
- $a Lamy, B $u Laboratory of Clinical Microbiology, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, INSERM U1065 (C3M), Nice, France.
- 700 1_
- $a Mareković, I $u Department of Clinical and Molecular Microbiology, University Hospital Centre Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia.
- 700 1_
- $a Miciuleviciene, J $u Vilnius City Clinical Hospital, Vilnius, Lithuania.
- 700 1_
- $a Müller Premru, M $u Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
- 700 1_
- $a Pascual, A $u Unidad de Enfermedades Infecciosas, Microbiologia y Medicina Preventiva, Hospital Universitario Virgen Macarena, Departamento de Microbiología, Universidad de Sevilla, Instituto de Biomedicina de Sevilla (IBiS), Sevilla, Spain.
- 700 1_
- $a Pournaras, S $u Laboratory of Clinical Microbiology, Attikon Hospital, National and Kapodistrian University of Athens, Athens, Greece.
- 700 1_
- $a Saegeman, V $u Department of Infection Control and Epidemiology, University Hospitals Leuven, Leuven, Belgium.
- 700 1_
- $a Schønheyder, H C $u Department of Clinical Microbiology, Aalborg University Hospital, Aalborg, Denmark.
- 700 1_
- $a Schrenzel, J $u Bacteriology Laboratory, Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.
- 700 1_
- $a Strateva, T $u Department of Medical Microbiology, Faculty of Medicine, Medical University of Sofia, Sofia, Bulgaria.
- 700 1_
- $a Tilley, R $u Department of Microbiology, University Hospitals Plymouth NHS Trust, Plymouth, UK.
- 700 1_
- $a Wiersinga, W J $u Department of Infectious Diseases and Centre for Experimental Molecular Medicine, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, the Netherlands.
- 700 1_
- $a Zabicka, D $u National Medicines Institute, Warsaw, Poland.
- 700 1_
- $a Carmeli, Y $u Division of Epidemiology, Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel.
- 700 1_
- $a Becker, K $u Institute of Medical Microbiology, University Hospital Münster, Münster, Germany. Electronic address: kbecker@uni-muenster.de.
- 710 2_
- $a ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES)
- 773 0_
- $w MED00001139 $t Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases $x 1469-0691 $g Roč. 25, č. 11 (2019), s. 1399-1407
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30980927 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200525092234 $b ABA008
- 999 __
- $a ok $b bmc $g 1525320 $s 1096518
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 25 $c 11 $d 1399-1407 $e 20190410 $i 1469-0691 $m Clinical microbiology and infection $n Clin Microbiol Infect $x MED00001139
- LZP __
- $a Pubmed-20200511
